Novel drugs developer to treat unmet medical needs of patients with high cardiovascular and pancreatitis risks with goals beyond those of current therapies.
Histotripsy is a non-invasive soft tissue ablation modality that mechanically homogenizes target tissue resulting in complete cellular destruction with no thermal injury.
Grand Angels® will make investments that will have a positive effect on our region through business growth, job creation, and the attraction and retention of local talent.
Investments with impact will be the result of engaged, experienced business leaders providing both capital and wisdom to entrepreneurs.
Through mentoring, strategic advice, expanding networks and connections to customers, management and venture capital, Grand Angels investments fuel the entrepreneurial economy of innovative companies throughout Michigan. Grand Angels typically invests from $250K to $1M in early-stage companies.